| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Purcell Michael J. serves as a Director at CTRVP and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 3 buys and 0 sells. Those positions are worth an estimated $1.3M at current prices.
The biggest single holding is IMXI (~$1.1M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 7,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | CTRVP Hepion Pharmaceuticals, Inc. | Director | Buy | 2,000,000 | $0.05 | $100,000.00 | +160.0% | - | - | |
| Apr 21, 2026 | CTRVP Hepion Pharmaceuticals, Inc. | Director | Buy | 1,250,000 | $0.04 | $50,000.00 | New | - | - | |
| Nov 18, 2021 | IMXI International Money Express, Inc. | Director | Buy | 7,000 | $15.07 | $105,460.60 | +24.7% | +6.5% | +35.1% |